
Glaukos Corporation GKOS
$ 121.48
0.5%
Quarterly report 2025-Q2
added 08-04-2025
Glaukos Corporation Total Non Current Liabilities 2011-2026 | GKOS
Annual Total Non Current Liabilities Glaukos Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 87.4 M | 2.74 M | 846 K | 159 K | 1.11 M | 9.36 M | 18.2 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 87.4 M | 159 K | 17.1 M |
Total Non Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | ||
|
iRhythm Technologies
IRTC
|
119 M | $ 122.35 | 0.73 % | $ 3.92 B | ||
|
Alcon
ALC
|
6.05 B | $ 75.8 | -0.08 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
239 K | $ 3.96 | -0.75 % | $ 183 M | ||
|
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 10.99 | 1.48 % | $ 26.7 M | ||
|
The Cooper Companies
COO
|
1.54 B | $ 64.42 | -0.82 % | $ 12.8 B | ||
|
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | ||
|
Haemonetics Corporation
HAE
|
405 M | $ 59.93 | 0.52 % | $ 3.02 B | ||
|
electroCore
ECOR
|
1.42 M | $ 6.18 | -0.08 % | $ 52.4 K | ||
|
ICU Medical
ICUI
|
66.7 M | $ 124.82 | 0.22 % | $ 3.08 B | ||
|
Envista Holdings Corporation
NVST
|
1.91 B | $ 26.8 | -0.89 % | $ 4.5 B | ||
|
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
418 M | $ 482.22 | 0.71 % | $ 172 B | ||
|
Pulse Biosciences
PLSE
|
6.72 M | $ 23.02 | -5.07 % | $ 1.55 B | ||
|
Microbot Medical
MBOT
|
760 K | $ 2.2 | 0.92 % | $ 101 M | ||
|
STAAR Surgical Company
STAA
|
12.5 M | $ 25.67 | 3.34 % | $ 1.27 B | ||
|
STERIS plc
STE
|
1.53 B | $ 221.8 | -0.77 % | $ 21.9 B | ||
|
Masimo Corporation
MASI
|
56 M | $ 178.63 | -0.04 % | $ 9.52 B | ||
|
Milestone Scientific
MLSS
|
1.4 M | $ 0.32 | -1.27 % | $ 26.3 M | ||
|
InfuSystem Holdings
INFU
|
35 M | $ 10.34 | 0.68 % | $ 214 M | ||
|
Stereotaxis
STXS
|
1.65 M | $ 1.93 | -1.53 % | $ 176 M | ||
|
Merit Medical Systems
MMSI
|
626 M | $ 68.58 | -0.04 % | $ 4.06 B | ||
|
Teleflex Incorporated
TFX
|
2.77 B | $ 136.56 | -0.07 % | $ 6.09 B | ||
|
Utah Medical Products
UTMD
|
5.25 M | $ 67.17 | -1.03 % | $ 218 M | ||
|
West Pharmaceutical Services
WST
|
427 M | $ 306.16 | -1.14 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 11.91 | 0.08 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
2.38 M | $ 0.65 | 0.2 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
9.93 M | $ 52.1 | 2.24 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
19.3 M | $ 113.45 | 0.49 % | $ 2.57 B | ||
|
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
41.7 M | $ 21.38 | -1.57 % | $ 985 M | ||
|
Baxter International
BAX
|
7.05 B | $ 18.16 | -1.39 % | $ 9.32 B | ||
|
ResMed
RMD
|
1.05 B | $ 219.85 | 0.15 % | $ 32.1 B | ||
|
AtriCure
ATRC
|
261 M | $ 29.28 | 3.79 % | $ 1.4 B | ||
|
Harvard Bioscience
HBIO
|
58.5 M | $ 6.86 | 1.18 % | $ 305 M | ||
|
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
148 M | $ 11.1 | -0.89 % | $ 453 M | ||
|
Becton, Dickinson and Company
BDX
|
25 B | $ 152.14 | -1.74 % | $ 43.8 B | ||
|
Nephros
NEPH
|
1.61 M | $ 2.87 | 1.06 % | $ 29.8 M | ||
|
OraSure Technologies
OSUR
|
22.5 M | $ 3.0 | -1.64 % | $ 220 M | ||
|
Repligen Corporation
RGEN
|
701 M | $ 117.6 | 3.1 % | $ 6.55 M |